✦ LIBER ✦

Monoclonal antibodies in the detection and therapy of micrometastatic epithelial cancers

✍ Scribed by Gert Riethmüller; Judith P. Johnson

Book ID: 113404869
Publisher: Elsevier Science
Year: 1992
Tongue: English
Weight: 142 KB
Volume: 2
Category: Article
ISSN: 0960-9822
DOI: 10.1016/0960-9822(92)90121-p

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Monoclonal Antibodies in Cancer Detectio

Monoclonal Antibodies in Cancer Detection and Therapy

✍ Stephen J. Kennel, Kathy Flynn, Linda Foote and Trish Lankford 📂 Article 📅 1984 🏛 University of California Press 🌐 English ⚖ 330 KB

Monoclonal antibodies and therapy of hum

Monoclonal antibodies and therapy of human cancers

✍ Ada Funaro; Alberto L Horenstein; Piera Santoro; Cristina Cinti; Armando Gregori 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 980 KB

Monoclonal antibodies in the study and t

Monoclonal antibodies in the study and therapy of hematopoietic cancers

✍ Dana C. Matthews; Franklin O. Smith; Irwin D. Bernstein 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 142 KB

Monoclonal antibodies in the study and t

Monoclonal antibodies in the study and therapy of hematopoietic cancers

✍ Dana C Matthews; Franklin O Smith; Irwin D Bernstein 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 904 KB

Recent advances utilizing monoclonal antibodies to phenotype acute leukemias have revealed no prognostic significance of the expression of lymphoid-associated antigens by acute myeloid leukemia blasts and conflicting results regarding 'biphenotypic' acute myeloid leukemia. Several studies treating p

Complement in monoclonal antibody therap

Complement in monoclonal antibody therapy of cancer

✍ Rogers, Laura M.; Veeramani, Suresh; Weiner, George J. 📂 Article 📅 2014 🏛 Springer-Verlag 🌐 English ⚖ 390 KB

Current applications of monoclonal antib

Current applications of monoclonal antibodies for the therapy of hematopoietic cancers

✍ David A. Scheinberg 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 803 KB

Recent trials of monoclonal antibodies in patients with leukemias or lymphomas have demonstrated the remarkable potency of these agents to kill tumor cells specifically and safely. New molecular biological and radiochemical techniques are also allowing rapid inroads into the remaining obstacles to t